Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Xanthine oxidase inhibitors (XOI), classified as purine-like (allopurinol and oxypurinol) and non-purine (febuxostat and topiroxostat) XOI, present antioxidant properties by reducing the production of reactive oxygen species derived from purine metabolism. Oxidative stress is an importan...

Descripción completa

Detalles Bibliográficos
Autores principales: Bredemeier, Markus, Lopes, Lediane Moreira, Eisenreich, Matheus Augusto, Hickmann, Sheila, Bongiorno, Guilherme Kopik, d’Avila, Rui, Morsch, André Luis Bittencourt, da Silva Stein, Fernando, Campos, Guilherme Gomes Dias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804046/
https://www.ncbi.nlm.nih.gov/pubmed/29415653
http://dx.doi.org/10.1186/s12872-018-0757-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804046/
https://www.ncbi.nlm.nih.gov/pubmed/29415653
http://dx.doi.org/10.1186/s12872-018-0757-9

Ejemplares similares